Sunitinib in Treating Patients With Recurrent Malignant Gliomas

NCT00499473 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

31

Enrollment

NIH

Sponsor class

Conditions

Adult Anaplastic Astrocytoma
Adult Diffuse Astrocytoma
Adult Giant Cell Glioblastoma
Adult Glioblastoma
Adult Gliosarcoma
Adult Mixed Glioma
Adult Oligodendroglioma
Adult Pineal Gland Astrocytoma

Interventions

DRUG: sunitinib malate
OTHER: pharmacological study

Sponsor

National Cancer Institute (NCI)